Cargando…

Contrasting benefits of different artemisinin combination therapies as first-line malaria treatments using model-based cost-effectiveness analysis

There are currently several recommended drug regimens for uncomplicated falciparum malaria in Africa. Each has different properties that determine its impact on disease burden. Two major antimalarial policy options are artemether–lumefantrine (AL) and dihydroartemisinin–piperaquine (DHA–PQP). Clinic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Okell, Lucy C., Cairns, Matthew, Griffin, Jamie T., Ferguson, Neil M., Tarning, Joel, Jagoe, George, Hugo, Pierre, Baker, Mark, D’Alessandro, Umberto, Bousema, Teun, Ubben, David, Ghani, Azra C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Pub. Group 2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4263185/ https://www.ncbi.nlm.nih.gov/pubmed/25425081 http://dx.doi.org/10.1038/ncomms6606

Ejemplares similares

Modelling the Impact of Artemisinin Combination Therapy and Long-Acting Treatments on Malaria Transmission Intensity
por: Okell, Lucy C, et al.
Publicado: (2008)

Reduction of transmission from malaria patients by artemisinin combination therapies: a pooled analysis of six randomized trials
por: Okell, Lucy C, et al.
Publicado: (2008)

Assessing the potential impact of artemisinin and partner drug resistance in sub-Saharan Africa
por: Slater, Hannah C., et al.
Publicado: (2016)

Factors determining the occurrence of submicroscopic malaria infections and their relevance for control
por: Okell, Lucy C., et al.
Publicado: (2012)

Modelling the benefits of long-acting or transmission-blocking drugs for reducing Plasmodium falciparum transmission by case management or by mass treatment
por: Bretscher, Michael T., et al.
Publicado: (2017)

The Potential Contribution of Mass Treatment to the Control of Plasmodium falciparum Malaria
por: Okell, Lucy C., et al.
Publicado: (2011)

A comparison of the duration of post-treatment protection of artemether-lumefantrine, dihydroartemisinin-piperaquine and artesunate-amodiaquine for the treatment of uncomplicated malaria
por: Bretscher, Michael T, et al.
Publicado: (2014)

Reducing Plasmodium falciparum Malaria Transmission in Africa: A Model-Based Evaluation of Intervention Strategies
por: Griffin, Jamie T., et al.
Publicado: (2010)

Global patterns of submicroscopic Plasmodium falciparum malaria infection: insights from a systematic review and meta-analysis of population surveys
por: Whittaker, Charles, et al.
Publicado: (2021)

Revisiting the circulation time of Plasmodium falciparum gametocytes: molecular detection methods to estimate the duration of gametocyte carriage and the effect of gametocytocidal drugs
por: Bousema, Teun, et al.
Publicado: (2010)

Seasonality in malaria transmission: implications for case-management with long-acting artemisinin combination therapy in sub-Saharan Africa
por: Cairns, Matthew E, et al.
Publicado: (2015)

How delayed and non-adherent treatment contribute to onward transmission of malaria: a modelling study
por: Challenger, Joseph D, et al.
Publicado: (2019)

Mathematical Modelling to Guide Drug Development for Malaria Elimination
por: Slater, Hannah C., et al.
Publicado: (2017)

Hitting Hotspots: Spatial Targeting of Malaria for Control and Elimination
por: Bousema, Teun, et al.
Publicado: (2012)

Estimates of the changing age-burden of Plasmodium falciparum malaria disease in sub-Saharan Africa
por: Griffin, Jamie T., et al.
Publicado: (2014)

Linking the incidence and age patterns of clinical malaria to parasite prevalence using a mathematical model
por: Griffin, Jamie T, et al.
Publicado: (2012)

Assessing the impact of imperfect adherence to artemether-lumefantrine on malaria treatment outcomes using within-host modelling
por: Challenger, Joseph D., et al.
Publicado: (2017)

Scale-up of Malaria Rapid Diagnostic Tests and Artemisinin-Based Combination Therapy: Challenges and Perspectives in Sub-Saharan Africa
por: Bastiaens, Guido J. H., et al.
Publicado: (2014)

Mapping sulphadoxine-pyrimethamine-resistant Plasmodium falciparum malaria in infected humans and in parasite populations in Africa
por: Okell, Lucy C., et al.
Publicado: (2017)

Artemisinin resistance and malaria elimination: Where are we now?
por: Hanboonkunupakarn, Borimas, et al.
Publicado: (2022)

Modelling the Protective Efficacy of Alternative Delivery Schedules for Intermittent Preventive Treatment of Malaria in Infants and Children
por: Cairns, Matthew, et al.
Publicado: (2011)

Dried blood spots as a source of anti-malarial antibodies for epidemiological studies
por: Corran, Patrick H, et al.
Publicado: (2008)

Residual Plasmodium falciparum Parasitemia in Kenyan Children After Artemisinin-Combination Therapy Is Associated With Increased Transmission to Mosquitoes and Parasite Recurrence
por: Beshir, Khalid B., et al.
Publicado: (2013)

Overuse of artemisinin-combination therapy in Mto wa Mbu (river of mosquitoes), an area misinterpreted as high endemic for malaria
por: Mwanziva, Charles, et al.
Publicado: (2008)

Modelling the cost-effectiveness of introducing the RTS,S malaria vaccine relative to scaling up other malaria interventions in sub-Saharan Africa
por: Winskill, Peter, et al.
Publicado: (2017)

Rapid Assessment of Malaria Transmission Using Age-Specific Sero-Conversion Rates
por: Stewart, Laveta, et al.
Publicado: (2009)

A model of parity-dependent immunity to placental malaria
por: Walker, Patrick G. T., et al.
Publicado: (2013)

Malaria morbidity and mortality in Ebola-affected countries caused by decreased health-care capacity, and the potential effect of mitigation strategies: a modelling analysis
por: Walker, Patrick G T, et al.
Publicado: (2015)

Heterogeneity in malaria exposure and vaccine response: implications for the interpretation of vaccine efficacy trials
por: White, Michael T, et al.
Publicado: (2010)

Lack of K13 mutations in Plasmodium falciparum persisting after artemisinin combination therapy treatment of Kenyan children
por: Muwanguzi, Julian, et al.
Publicado: (2016)

The design and statistical power of treatment re-infection studies of the association between pre-erythrocytic immunity and infection with Plasmodium falciparum
por: White, Michael T, et al.
Publicado: (2013)

COVID-19 and the difficulty of inferring epidemiological parameters from clinical data – Authors' reply
por: Verity, Robert, et al.
Publicado: (2021)

Persistence of mRNA indicative of Plasmodium falciparum ring-stage parasites 42 days after artemisinin and non-artemisinin combination therapy in naturally infected Malians
por: Mahamar, Almahamoudou, et al.
Publicado: (2021)

Pre-existing partner-drug resistance to artemisinin combination therapies facilitates the emergence and spread of artemisinin resistance: a consensus modelling study
por: Watson, Oliver J, et al.
Publicado: (2022)

Modelling population-level impact to inform target product profiles for childhood malaria vaccines
por: Hogan, Alexandra B., et al.
Publicado: (2018)

Global investment targets for malaria control and elimination between 2016 and 2030
por: Patouillard, Edith, et al.
Publicado: (2017)

The US President's Malaria Initiative, Plasmodium falciparum transmission and mortality: A modelling study
por: Winskill, Peter, et al.
Publicado: (2017)

The Benefits of Artemisinin Combination Therapy for Malaria Extend Beyond the Individual Patient
por: Garner, Paul, et al.
Publicado: (2005)

Modelling the impact of vector control interventions on Anopheles gambiae population dynamics
por: White, Michael T, et al.
Publicado: (2011)

Transmission of Artemisinin-Resistant Malaria Parasites to Mosquitoes under Antimalarial Drug Pressure
por: Witmer, Kathrin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_cbfccqmqe4077l5fk4m3r92j2e